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SUMMARY 
Elimination of macrophages with high-molecular dextran sulphate (OS) 
markedly impairs resistance of mice to primary infection with smooth, 
virulent strains of Salmonella typhimurium, whereas stimulation of this 
system by killed Bordetella pertussis organisms increases resistance. In 
infection with rough, avirulent strains of S. iyphimurium the elimination 
of macro phages was not followed by an essential loss of resistance, and it 
appears that other non-specific defence mechanisms, for example the 
complement system, may have compensated for the lack of macrophages. 
Macrophages, therefore, play an important role in defence during primary 
infection with virulent strains. 
In immunity to challenge infection with S. typhimurium, macrophages 
play an even more significant role. Treatment with OS completely removes 
immunity, and both humoral and cell-mediated immune mechanisms seem 
to require the participation of macrophages. 
KEY-WORDS: Macrophage, Salmonella typhimurium; Dextran sulphate, 
Mouse, 0 antigen, Bordeiella pertussis. 
INTRODUCTION 
Macrophages are of particular importance in the defence against infec-
tion by intracellular bacteria such as Listeria monocytogenes [16]. Elimi-
nation of these, cells by treatment with a high-molecular weight dextran 
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sulphate (DS) strongly impairs the defence system (10], whereas stimulation 
of macrophage activity by killed Bordelella pertussis cells strengthens 
host resistance (12]. 
Virulent strains of Salmonella typhimurium are also said to be facul-
tative intracellular pathogens [7, 24], which implies that they could survive 
and eventually multiply within macrophages. Indeed, after parenteral 
injection these bacteria are found primarily in the reticulo-endothelial 
organs such as spleen and liver [21]. Mice with a genetically determined 
low macrophage activity are more sensitive to Salmonella infection than 
are those with high macrophage activity [9]. In addition, peritoneal macro-
phages from resistant mice kill Salmonella more efficiently, in vitro, than 
those from susceptible animals (18]. Nevertheless, it has been doubted 
whether in Salmonella infection the macrophages play an indispensable 
role. During primary infection at least the polymorphonuclear leukocytes 
rather than the macrophages are prominent in infective foci in spleen and 
liver of mice [20]. 
We report here an attempt to further elucidate the role of macro phages 
during primary infection with S. typhimurium by monitoring the course 
of infection after treatment with either blocking or stimulating agents. 
In particular, the role of macrophages - and of another non-specific 
defence mechanism, i. e. the complement system - in infection with 
different O-antigen mutants were examined. Such genetically determined 
alterations [23] of the biochemical composition of the cell envelope (14] 
considerably influence virulence [22]. 
In addition, the role of macrophages in immunity to Salmonella reinfec-
tion was studied. Immunity to Listeria reinfection is mediated exclusively 
by cellular mechanisms, whereby the macrophages are the proper effector 
cells (17]. Without these cells, immunity cannot be expressed [5]. In murine 
salmonellosis, however, both humoral (13] and cell-mediated [2) mechanisms 
participate. The role of macrophages in this particular situation is not 
defined. Although they are implicated according to Nakonezna and Hsu [20], 
Marecki et al. (19] reported that macrophages of previously infected animals 
showed no enhanced bactericidal activity. 
MATERIALS AND METHODS 
Mice. 
Female NMRI mice weighing about 25-30 g were obtained from the Central 
Institute for Laboratory Animals (Hannover, Fed. Rep. of Germany) in a SPF 
state. They were held under standard conditions and fed with pellets and water 
ad libitum. 
DS = dextran sulphate. 
i.p. = intraperiloneally. 
Lv. = intravenously. 
lab. = laboratory. 
PO = pertussis organism. 
SPF = specific pathogen-free. 
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TABLE I. - Strains of « S. typhimurium ». 
Running 
Designation name 
1366/74 lab. 
SF 1397 LT2 
SF 1512 SR 
SF 1572 Rd, 
slrre. = streptomycin-resistant. 
lel r•• = tetracycline-resistant. 
r/c- = repeating polymerase-deficient unit. 
r/aG- = glycosyltransferase-deficient. 
Bacteria. 
Genotype 
sir r ea 
lel r • • 
slr fes 
slrres 
r/c-
slrr •• 
r/aG-
O-antigen phenotype 
smooth 
smooth LT2 
semi-rough form 
rough form d, 
Strain of S. typhimurium are listed in table I. Strains designated SF were 
obtained from Dr G. Schmidt ( 'lax Planck, Institute for Immunology, Freiburg, 
Fed. Rep. of Germany). The laboratory (lab.) strain 1366/74 was from the culture 
collection from the Institute of Hygiene and Microbiology, originally isolated from 
a stool specimen of a patient with diarrhoea. For infection of mice, fresh cultures 
of these bacteria were prepared by incubating in tryptose broth for 18 h at 370 C. 
A suspension of B. pertussis organisms (PO; phase I, heat-killed at 560 C for 
30 min, not absorbed, treated with merthiolate 1/10,000) was kindly supplied by 
Behringwerke (Marburg, Fed. Rep. of Germany). An appropriate suspension 
containing 109 cells per 0.2 ml was injected intraperitoneally (i.p.) into a mouse 
7 days prior to infection. 
Enumeration of bacteria per spleen. 
Mice were infected intravenously (i.v.) via a tail vein. At intervals after infec-
tion animals were killed and the spleens were removed a eptically. After mechanical 
homogenization in an (( Omnimixer » (Sorvall, Newton, USA), duplicate samples of 
an appropriate dilution were pipetted into plastic Petri dishes and mixed with 
liquified tryptose agar (1.5 %). The numbers of colonies were counted after 24 h 
at 370 C. Mice (4-6) were examined per group and per day; the means and the 
standard error of the means were calculated. 
Transfer of immune cells. 
'lice were immunized by infection with 104 cells of the lab. strain of S. typhi-
murium. Four weeks after infection 2 ml of thioglycollate broth were injected 
i.p. into a mouse. Two days later, cells in the peritoneal cavity were recovered 
by peritoneal washing with cell culture medium (RPMI-1640 with 20-nmol Hepes 
buffer, Flow Laboratories, Bonn, Fed. Rep. of Germany) as recommended by 
Hahn et al. [11]. Cells were washed and counted in a counting chamber. A appro-
priate suspension of these peritoneal cells was injected i.v. into a recipient mouse 
together with the bacteria. 
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Production 0/ antiserum. 
Rabbits were injected Lv. 8 times every 4 days with 0.5 up to 2 ml of a dense 
suspension of heat-killed cells of S. typhimurium. The agglutination titre in the 
serum was 1/40,000. A volume of 0.5 ml of this antiserum was injected i. p. into 
a non-immunized recipient mouse 1 h before infection. 
DS. 
DS 500 with a molecular weight of 500,000 was purchased from « Serva Fein-
biochemica » (Heidelberg, Fed. Rep. of Germany). One mg of this compound 
dissolved in 0.2 ml of saline was injected into a mouse 18 h before infection. 
Serum bactericidal assay. 
Serum sensitivity of the various strains of S. iyphimurium was assessed accord-
ing to Taylor and Hughes [25]. Fresh normal human serum was obtained from 
healthy volunteers on the day of the test. Bacteria were grown to mid logarithmic 
phase, washed and resuspended to about 2-5 X 106 cells /m!. Bacterial counts 
were made before and after 2 h incubating at 370 C of a mixture of 0.2 ml of this 
suspension with 1.8 ml of undiluted serum or of 5 % serum, respectively. Survival 
is expressed as the percentage of the initial inoculum (mean of 2 independent 
tests). 
RESULTS 
1) Effects of DS on primary infection. 
Only 1 mouse out of 10 died after infection with 5 x 105 cells of the 
lab. strain of S. typhimurium. If 1 mg DS was given 1 day prior to infection, 
all of the 11 mice died within 8 days (fig. 1). 
When infection was performed with a lower dose, i. e. with a non-lethal 
dose of 104 cells of the lab. strain, mice pretreated with DS showed increased 
numbers of bacteria in their spleen in comparison to normal control ani-
mals (data not shown). 
Pretreatment with DS was especially deleterious to mice infected with 
104 cells of the smooth LT2 strain of S. typhimurium. Multiplication was 
markedly increased in DS-treated animals (fig. 2A). The intermediate 
variant SR (fig. 2B) and the rough Rd1 strain (fig. 2C) were obviously less 
virulent, since after infection of mice with 105 cells, i. e. a dose 10-fold 
higher than that given of L T2, lower bacterial counts per spleen were 
found. In addition, the numbers of these avirulent bacteria in the spleen 
did not increase but rather steadily decreased with time. This occurred 
even in the DS-treated mice, although bacterial elimination was somewhat 
impeded. 
2) Effect of DS on actively immunized mice. 
Once mice had survived primary infection with 104 cells of virulent 
S. typhimurium, they were highly resistant in comparison to non-immune 
controls to reinfection with 106 cells of S. typhimurium given 4 weeks 
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FIG. 1. - Cumulative mortality rates of mice infected 
with 5 X 10' cells of a virulent strain of S. typhimurium (lab. strain) . 
o = control mice; 11 mice were used . 
• = mice treated with 1 mg DS on day - 1; 10 mice were used. 
later. Such a state of immunity was not only completely suppressed by 
treatment with DS, given 1 day prior to challenge infection, but mice 
treated in this way died even more promptly than non-immunized control 
animals (fig. 3). 
This finding was substantiated by the enumeration of bacterial counts 
per spleen. On day 2 of challenge infection with L T2, immunized mice had 
TABLE II. - Effect of DS on immunity to challenge infection with LT 2. 
Non-primed control mice. 
Mice infected with 10' cells of S. typhi-
mllrium 4 weeks previously 
Mice infected with 10' cells of S. typhi-
murium 4 weeks previously; 
1 mg DS i.p. on day -1 
Mice infected with 10' cells of S. typlli-
murium 4 weeks previously; 
1 mg DS i.p. on day +1 
Viable counts of 
S. typhimurium (*) 
211,760 ± 87,000 
18,6 ± 3,2 
54,570 ± 35,910 
47 ± 19 
(*) umber of S. typhimurium in the spleen ( x 102) of mice 
infected 2 days previously with 10' cells of S. typhimurium (mean and 
standard error of the mean; 4 mice were used per group). 
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FIG. 2. - Bacterial counts per spleen of infected mice. 
A = 10' cells of the strain LT2; 
B = 10' cells of the strain SR; 
C = 10' cells of the strain Rd •. 
0, Il, 0 = control mice; 
e , ~, • = mice treated with 1 mg DS on day - 1. 
2 4 
considerably lower bacterial counts than non-primed controls. DS-pretreat-
ment removed immunity, since rather high numbers of bacteria are found 
equivalent to non-primed controls. If DS is given 1 day after challenge 
infection, there is pratically no more influence on expression of immunity 
(table II). 
3) Effect of DS on animals passively immunized with antiserum. 
If mice were passively immunized with specific antiserum, they were 
partially protected against a low infectious dose of the lab. strain of S. typhi-
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murium. On day 2 after infection, bacterial counts per spleen were clearly 
reduced in comparison to untreated controls. This protective effects was 
completely lacking if these mice had been treated with DS 1 day before 
infection (table Ill). 
100 
90 
;'! 80 
c 70 
11\ 60 
.. 
-~ 50 
>- 40 
-
2 30 0 
E 20 
10 
0 ~ 
~ 
2 3 4 5 6 7 8 20 
days after infection 
FIG. 3. - Cumulative mortality rates of mice infected with 1()6 cells 
a/the virulent lab. strain of S. typhimurium. 
tJ. = control mice; 
o = mice immunized by prior infection with 10' cells of S. typhimurium; 
• = mice immunized by prior infection; treated with 1 mg DS on day - 1 before challenge infec-
tion (11 mice were used per group). 
TABLE Ill. - Effect of DS on protection afforded 
by passively applied antiserum. 
Untreated control mice 
Mice treated with 1 mg DS i.p. on day - 1 
Mice injected i.p. with 0.5 ml antiserum 1 h 
before infection 
Mice treated with 1 mg DS i.p. on day -1; 
injected with 0.5 ml of antiserum 1 h before 
infection 
Viable counts of 
S. typhimurium (*) 
28 ± 13 
875 ± 247 
2 ± 1 
752 ± 415 
(*) number of S . typhimurium in the spleen ( x H)3) of mice infected 
2 days previously with 10" cells of S. typhimurium (mean and standard 
error of the mean; 4 mice were used per group). 
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4) Effect of DS on animals passively immunized by cell transfer. 
If mice were injected with 107 peritoneal cells from immunized donor 
mice, they were passively protected against infection, at least partially. 
This effect, however, was no longer seen in recipient animals treated with 
DS 1 day before infection (table IV). 
TABLE IV. - Effect of DS on protection afforded 
by passively applied peritoneal cells of immune animals. 
Control mice 
Mice treated with 1 mg DS i.p. on day -1 
Mice injected i.v. with 10 7 peritoneal cells from mice infected 
with 10' cells of S. typhimurium 4 weeks previously 
Mice injected i.v. with 10 7 peritoneal cells from mice infected 
with 10' cells of S. typhimurium 4 weeks previously; treated 
with 1 mg DS i.p. on day - 1 
Viable counts of 
S. typhimurium (*) 
128 ± 58 
7,071 ± 2,918 
5 ± 1 
2,631 ± 1,796 
(*) Number of S. typhimurium in the spleen (x 10") of mice infected 2 days previously with 
10' cells of S . typhimurium (means and standard error of the mean; 4 mice were used per group). 
5) Effect of PO on primary infection. 
Mice treated with 109 PO, 7 days prior to infection with a low dose of 
the lab. strain of S. typhimurium, were more resistant than untreated 
animals. In the spleens of treated mice a markedly lower number of bac-
teria was found (table V). 
TABLE V. - Effects of PO on primary infection. 
Control mice 
Mice injected with 109 PO i.p. on day -7 
Viable counts of S. typhimurium (*) 
days after infection 
+4 + 7 
27,600 ± 11,600 16,600 ± 1,600 
1,310 ± 580 1,310 ± 650 
(*) Number of S. typhimurium in the spleen of mice infected with 10" cells of S. typhimurium 
(mean and standard error of the mean; 5 mice were used per group). 
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6) In vitro susceptibility of different Salmonella strains to normal serum. 
All strains of S. typhimurium maintained over 100 % survival when 
the serum was preheated at 560 C for 30 min. But the 4 strains are not 
equally sensitive to fresh normal human serum. When they were incubated 
with undiluted serum, only the lab. strain maintained viability, although 
an increase in counts was not observed. 
The rough and semi-rough mutants (Rd1 and SR) were also very sensi-
tive to diluted serum. Both smooth strains were considerably less sensitive; 
only the lab. strain showed an increase in counts after 2 h (table VI). 
TABLE VI. - Susceptibility of different strains of « S. typhimurium» 
to fresh normal human serum (*). 
Bacterial strains 
Bacterial strains 
Concentration 
of serum lab LT2 SR 
90 % 96 < 2 0 
5% 154 38 < 5 
(*) Percentage of bacteria surviving from 2-5 X 10' cells per ml inoculum. 
DISCUSSION 
Rd 1 
0 
< 5 
The macrophage is said to play an important role in the defence of 
mice against systemic infection with S. typhimurium [4, 9, 21). Damage 
of the macrophage system by treatment with DS, which is known to elimi-
nate an essential portion of the macrophage system [10], decreases resis-
tance to infection with virulent strains of S. typhimurium. Bacterial multi-
plication is therefore supported (fig. 2A) and death of the host is pro-
moted (fig. 1). This strongly confirms experiments in which the macrophage 
system is blocked by silica [8). 
Stimulation of the macrophage system by killed Corynebacterium parvum 
cells increases resistance to Salmonella infection [4). Equally, killed PO 
- which have been shown to enhance resistance to Listeria infection via 
the macrophage system [6) - enhance resistance to infection with S. typhi-
murium (table V). This finding confirms the results of Andersen [1) which 
had been contradicted by CoIlins [4). 
These results favour the view that in infection with virulent cells of 
S. typhimurium, which are said to survive and multiply within macro-
phages [7, 24) , the activity of these host cells plays a certain role in the 
host-parasite relationship. 
Since avirulent cells of S. typhimurium are more sensitive to Idling 
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by peritoneal macrophages in culture [7], the lack of macrophages in vivo 
should lead to an even more prominent defect in resistance. This idea was 
studied with mutants of S. typhimurium possessing different O-antigen 
composition genetically defined. This part of the outer membrane consists 
of repeating units, an oligosaccharide chain of varying length, and of an 
outer core comprising several different sugars [14]. Whereas the smooth L T2 
strain has the complete structure, the syngeneic rfc-mutant SR lacks all 
but one of the repeating units, and the Rd 1 mutant has lost all polysaccha-
ride except three heptose molecules [23]. We found the deficient mutants to 
be clearly less virulent than the complete strain, confirming the work of 
Roantree [22]. In spite of a higher infective dose, the Rd1 strain was less 
numerous in the spleen even at day 1 after infection, and the bacterial 
counts steadily decreased, whereas the cells of the L T2 strain multiplied. 
The SR strain showed an intermediate response. In mice pretreated with 
DS and consequently largely depleted of macrophage activity [10], the 
avirulent bacteria did not persist, whereas multiplication of the L T2 
strain was strongly enhanced (fig. 2). 
It is concluded therefore that in infection of mice with virulent bacteria, 
macrophages are involved in resistance but not in infection by avirulent 
strains of S. typhimurium. This finding disproves the suggestion of Valto-
nen [26J that « phagocytosis by the reticulo-endothelial system is the res-
ponsible mechanism for O-antigen-dependen t differences in mouse virulence ». 
Since the avirulent bacteria are suppressed even in the macrophage 
depleted host, other defence mechanisms must be responsible. For example 
the O-antigen-deficient mutants are more sensitive than smooth strains to 
fresh human serum containing complement (table VI). This is in agreement 
with earlier data [3, 15]' It is possible that the complement system could 
destroy the avirulent bacteria in the absence of macro phages. 
During secondary infection, macrophages seem to be indispensable 
for the expression of immunity since damage of the macrophage system 
by DS completely removed the state of enforced defence (table 11, fig. 3). 
Apparently the macrophage represents the proper effector cell in immunity 
to Salmonella infection as is the case in infection with other intracellular 
pathogens such as L. monocytogenes [5, 17]. 
In contrast to Listeria infection, immunity to Salmonella infection is 
not only mediated by cellular [2] but also by humoral [13] mechanisms. 
Both humoral (table Ill) and cellular (table IV) immunity do require the 
macrophage as effector cell. Antiserum, said to afford a certain degree 
of protection [13] which is confirmed here (table Ill), is apparently unable 
to exert its beneficial action without the aid of an active macrophage system. 
Hence, when the macrophages are paralysed by DS, antiserum is no more 
effective. The transfer of immunity by peritoneal cells from immunized 
animals resulted in an increased resistance to infection [27]. This effect was 
destroyed by treatment with DS (table IV). 
In conclusion, macrophages appear to play an important role in infec-
tion with S. typhimurium, and only during infection with avirulent strains 
may these cells be replaced by other defence mechanisms. 
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RESUME 
LE ROLE DES MACROPHAGES 
AU COURS DE L'INFECTION PRIMAIRE OU SECO DAIRE DE LA SOURIS 
A VEC « SALMO ELLA TYPHIMURIUM » 
L'elimination des macrophages par le sulfate de dextrane (SD) de poids 
moleculaire eleve entraine une reduction de la resistance de la souris it une 
infection primaire avec des souches « smooth » virulentes de Salmonella 
iyphimurium. Par contre, la stimulation du systeme macrophagique par 
des cellules tuees de Bordetella pertussis entraine une augmentation de la 
resistance. Dans l'infection avec des souches « rough » avirulentes de 
S. typhimurium, l'elimination des macrophages n'est pas suivie d'une perte 
considerable de la resistance. Il semble, au contraire, que d'autres meca-
nismes de resistance non specifiques - l'intervention du complement, 
par exemple - puissent compenser chez la souris le deficit de la fonction 
macrophagique. Si donc Ies macrophages jouent un role important tout 
particulierement lors de l'infection avec des souches virulentes de S. typhi-
murium, leur role au cours d'une infection secondaire semble encore plus 
determinant puisque l'administration de SD a la souris immunisee supprime 
completement son etat d'immunite. Ainsi la participation des macrophages 
est essentielle, aussi bien pour l'immunite humorale que pour l'immunite 
cellulaire envers S. typhimurium : les macrophages sont les cellules effec-
trices indispensables a I'acquisition de cette immunite. 
MOTs-cLE:s : Macrophage, Salmonella typhimurium; Sulfate de dextrane, 
Souris, Antigene 0, Bordetella pertussis. 
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SUMMARY 
A TI-TUMOUR CYTOSTATIC AND CYTOTOXIC PROPERTIES 
OF PERITONEAL EXUDATE CELLS OF CONVENTIONAL 
AND GERM-FREE MICE, STIMULATED OR NOT 
BY « CORYNEBACTERIUM PARVUM » 
The treatment by Corynebacterium parvum induced an increase of 
peritoneal cell number in conventional mice but no modifications in germ-
free mice. Against YC8 tumoral target cells, cytostatic properties of 
peritoneal cells were of the same intensity in conventional and germ-free 
after C. paroum treatment. Against K.BALB cells, C. paroum treatment 
induced an increase of cytostatic properties from 9 to 93 % in conven-
tional mice and from 51 to 84 % in germ-free mice. Cytotoxic properties 
were increased by C. paroum in conventional mice but were inchanged 
in germ-free mice. The bacterial flore could play a role in the cytotoxic 
and cytostatic properties of peritoneal cells in conventional mice. 
KEY-WORDS: Tumour, Corynebacterium paroum, Immunoregulation, 
Peritoneal cell; Conventional and germ-free mice, Cytostasis, Cytotoxicity. 
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